RxDoctor Payments DataLook up a doctor →

Vadim Baram, MD

Psychiatry · Saint Louis, MONPI 1124007380

Payments from drug & device makers

$1,869,321in general payments, 2019–2025

Across 5,369 payments — averaging $348.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$502K
  • Neurocrine Biosciences, Inc.$324K
  • Vanda Pharmaceuticals Inc.$290K
  • Teva Pharmaceuticals USA, Inc.$247K
  • Avanir Pharmaceuticals, Inc.$189K
  • E.r. Squibb & Sons, L.L.C.$83K
  • plus $235K from 40 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alkermes, Inc.858$501,926
Neurocrine Biosciences, Inc.543$323,706
Vanda Pharmaceuticals Inc.535$289,657
Teva Pharmaceuticals USA, Inc.748$247,056
Avanir Pharmaceuticals, Inc.422$189,070
E.r. Squibb & Sons, L.L.C.155$82,978
Bioxcel Therapeutics, Inc.122$56,270
Acadia Pharmaceuticals Inc207$52,006
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)345$43,567
Noven Pharmaceuticals, Inc.19$14,598
Axsome Therapeutics, Inc.94$11,278
Johnson & Johnson138$9,790
Sunovion Pharmaceuticals Inc.228$9,759
Noven Therapeutics, LLC75$8,859
Takeda Pharmaceuticals U.S.A., Inc.46$8,701
Indivior Inc.99$7,894
Harmony Biosciences LLC74$1,995
Supernus Pharmaceuticals, Inc.97$1,574
AbbVie(2 entities)52$1,511
Bausch Health US, LLC178$1,422
Tris Pharma Inc68$1,307
Neos Therapeutics, LP68$1,058
Jazz Pharmaceuticals Inc.57$679
Sun Pharmaceutical Industries Inc.49$573
Janssen Scientific Affairs, LLC2$292
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC2$223
Eisai Inc.19$214
Merck11$196
Luye Pharma (USA) Ltd.3$170
Idorsia Pharmaceuticals US Inc16$170
Livanova USA, Inc.2$163
MDD US Operations, LLC2$138
Ironshore Pharmaceuticals Inc.14$137
Novo Nordisk3$60
Sage Therapeutics, LLC3$57
Almatica Pharma LLC3$49
Lilly USA, LLC2$44
Vertical Pharmaceuticals, LLC2$36
Alpha Cognition USA, Inc.1$32
Collegium Pharmaceutical, Inc.1$20
TMS Neurohealth Centers Inc.1$19
Braeburn Inc.1$15
Sumitomo Pharma America, Inc.1$15
Shire North American Group Inc1$15
Aytu Biopharma, Inc.1$13
Arbor Pharmaceuticals, Inc.1$12

How this compares

$1,869,321 in reported general payments places this provider in the 95th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri →

Medicare billing

Part B allowed, 2024
$210,312
Medicare patients
346
Services billed
2,153

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →